Study links limonene to CYP2C19 gene differences
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how a person’s CYP2C19 gene type affects how their body processes limonene (a citrus compound). The results may help researchers understand differences in drug and nutrient processing based on genetics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 44 years old (inclusive).
- Be of East Asian descent.
- You can be male or female.
- You must not be pregnant or breastfeeding.
- You must not have had serious allergy to limonene, citrus, bovine gelatin, or glycerin.
- You must not have a history of stroke or major heart blood-vessel problems, or chest pain/shortness of breath in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the things you're exposed to in your everyday environment—like air, water, and foods—may affect your health over time. By joining, you help researchers learn more about what keeps people healthy and what might cause illness.
This study checks how well your liver breaks down certain medications based on your genes. It aims to find new ways to predict your natural liver function, which could help doctors prescribe the right drug dose for you.
This study looks at how your genes affect the way your body handles medications. It aims to improve treatment by understanding genetic differences, especially if you take multiple medications.
This trial tests a dietary supplement called LIMICOL®-NG to see if it can lower LDL (bad) cholesterol in people with moderately high cholesterol. It may be an option if you are not already on cholesterol medication.
This study looks at how a specific gene (UGT2B17) affects how your body processes diclofenac, a common pain reliever. Healthy people aged 18 to 64 are needed to help understand genetic differences in drug metabolism.
This is a research study testing whether specific gene changes are linked to fatty liver and a cholesterol pattern that raises heart risk. It may help researchers understand who is most likely to develop these conditions and why, which could guide future prevention.
Hear when a new CYP2C19 Genetic Variants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.